Shin Nippon Biomedical Laboratories, Ltd. Share Price
Equities
2395
JP3379950003
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,502 JPY | +1.49% | +5.55% | -11.54% |
Sales 2024 * | 26.19B 165M 13.79B | Sales 2025 * | 31.5B 199M 16.59B | Capitalization | 62.53B 395M 32.92B |
---|---|---|---|---|---|
Net income 2024 * | 3.98B 25.09M 2.09B | Net income 2025 * | 5.3B 33.46M 2.79B | EV / Sales 2024 * | 3.13 x |
Net Debt 2024 * | 19.51B 123M 10.27B | Net Debt 2025 * | 18.93B 119M 9.97B | EV / Sales 2025 * | 2.59 x |
P/E ratio 2024 * |
15.7
x | P/E ratio 2025 * |
11.8
x | Employees | 1,344 |
Yield 2024 * |
3.33% | Yield 2025 * |
3.33% | Free-Float | 48.8% |
1 day | +1.49% | ||
1 week | +5.55% | ||
Current month | -1.05% | ||
1 month | -1.05% | ||
3 months | -14.07% | ||
6 months | -5.89% | ||
Current year | -11.54% |
Managers | Title | Age | Since |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 01/81/01 |
Shinji Nitanda
DFI | Director of Finance/CFO | 55 | 01/02/01 |
Terumasa Hirai
CMP | Compliance Officer | - | 01/84/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 01/81/01 |
Ichiro Nagata
BRD | Director/Board Member | 38 | 01/17/01 |
Sales & Marketing | 64 | 01/02/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.51% | 23 M€ | +1.75% | - | |
0.08% | 19 M€ | +3.83% | ||
0.01% | 18 M€ | +16.15% | - | |
0.01% | 144,586 M€ | +14.49% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1,502 | +1.49% | 205,300 |
25/24/25 | 1,480 | +0.61% | 147,900 |
24/24/24 | 1,471 | +1.59% | 170,300 |
23/24/23 | 1,448 | +1.05% | 163,700 |
22/24/22 | 1,433 | +0.70% | 241,100 |
Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.54% | 397M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 2395 Stock